Severe acute respiratory syndrome coronavirus 2 (SARS-Cov-2)-induced infection, the cause of coronavirus disease 2019 (COVID-19), is characterized by acute clinical pathologies, including various coagulopathies that may be accompanied by hypercoagulation and platelet hyperactivation. Recently, a new COVID-19 phenotype has been noted in patients after they have ostensibly recovered from acute COVID-19 symptoms. This new syndrome is commonly termed Long COVID/Post-Acute Sequelae of COVID-19 (PASC). We have collected all lab reported findings related to long covid and mapped to Human Phenotype Ontology (HPO) and their pathways.
Lab (Total reported symptoms: 23)
- Abnormal calcium phosphate regulating hormone level (HP:0100530)
- Abnormal circulating protein concentration (HP:0010876)
- Abnormality of fibrinolysis (HP:0040224)
- Decreased circulating calcifediol concentration (HP:0012053)
- Elevated circulating alkaline phosphatase concentration (HP:0003155)
- Elevated circulating alanine aminotransferase concentration (HP:0031964)
- Elevated circulating aspartate aminotransferase concentration (HP:0031956)
- Elevated circulating creatinine concentration (HP:0003259)
- Elevated circulating creatine kinase concentration (HP:0003236)
- Elevated circulating C-reactive protein concentration (HP:0011227)
- Elevated circulating thyroid-stimulating hormone concentration (HP:0002925)
- Elevated erythrocyte sedimentation rate (HP:0003565)
- Elevated gamma-glutamyltransferase level (HP:0030948)
- Hypocalcemia (HP:0002901)
- Hypofibrinogenemia (HP:0011900)
- Hyperglycemia (HP:0003074)
- Hypoglycemia (HP:0001943)
- Hypophosphatemia (HP:0002148)
- Increased circulating ferritin concentration (HP:0003281)
- Increased circulating interleukin 6 (HP:0030783)
- Increased circulating lactate dehydrogenase concentration (HP:0025435)
- Increased circulating NT-proBNP concentration (HP:0031185)
- Thrombocytopenia (HP:0001873)
